Putting BEACON into practice

Putting BEACON into practice

By Will Dunlop, Head of Market Access, Mundipharma International Limited  

Earlier this year I chaired Mundipharma International Limited’s satellite symposium at the HTAi annual meeting where we introduced the BEACON framework, which was the culmination of a joint project between Mundipharma International and a group of payer experts published in the peer reviewed journal PharmacoEconomics.1

The BEACON mnemonic is used to capture the key criteria considered by payers when reviewing medicines for reimbursement, and therefore help improve the alignment between HTA (Health Technology Assessment) bodies and industry in the key stages of drug development.

To follow up this launch event, at the 20th annual International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) European Congress in Glasgow (4-8th November), we will be hosting a satellite symposium to explore how the BEACON framework can be applied in practice. We want to bring BEACON to life and give audience members a better sense of how can be used to inform business decisions. Following a demonstration by our expert panel, we’ll be giving attendees at the symposium the opportunity to test BEACON for themselves in an interactive experience, using a hypothetical drug profile.

The Mundipharma International symposium session will be chaired by Meindert Boysen, Programme Director, Technology Appraisals at the National Institute for Health and Care Excellence (NICE). He will be joined on our panel by Health Economist Andrew Walker, from Salus Alba and Professor Ron Goeree, Professor Emeritus, McMaster University and Goeree Consulting Ltd, who was a co-author of the BEACON framework alongside myself.

I am proud that Mundipharma International engages with payers to understand their needs and takes an interest in tackling the traditional misalignment between HTA requirements and data collection during the drug development process.

Please do come and join us if you are at ISPOR to take part in what should be a fascinating event. The symposium – How to use the BEACON framework to help guide the drug development process and achieve patient access, is being held on Sunday 5 November at IPSOR’s 20th Annual European Congress, Scottish Event Campus (SEC), Glasgow, Scotland, from 6:45pm – 7:45pm in the Lomond Auditorium.

References:
1. Dunlop et al., PharmacoEconomics. “BEACON: A summary framework to overcome potential reimbursement hurdles.” Oct. 2016, volume 34, issue 10, pp1051-1065